Pharma News

The latest developments from pharmaceutical and biopharmaceutical companies, both innovator and generic-drug companies, and leading regulatory news.

Merck & Co. has agreed to acquire Pandion Therapeutics, a Watertown, Massachusetts-based company developing therapeutics for autoimmune diseases, for an approximate total equity value of $1.85 billion. Pandion is advancing a pipeline of...

Bristol-Myers Squibb (BMS) has announced that construction is underway for a new cell-therapy manufacturing facility at its biomanufacturing site in Devens, Massachusetts. The new cell-therapy facility will be located on BMS’s current 89-acre...